Approval · Notice of Compliance 16807 · 2015
OMEPRAZOLE: Notice of Compliance 16807
Issued April 17, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16807
- Date
- April 17, 2015
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- H+,K+-atpase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMEPRAZOLE | 02439018 | Dormant |
Medicinal ingredients
- OMEPRAZOLE MAGNESIUM 20 MG per TAB